Corinne Faivre-Finn Honored with the ESTRO 2025 Breur Award

Some of the biggest breakthroughs in medicine come from those who aren’t afraid to think differently—and Professor Corinne Faivre-Finn has certainly done just that. Her groundbreaking work in radiation oncology, especially in lung cancer treatment, has earned her a reputation as one of the leading experts in the field. Her outstanding contributions will be recognized with the Breur Award at ESTRO 2025, a prestigious honor that highlights the most impactful voices in radiation oncology.

A Career Focused on Innovation and Care

Professor Faivre-Finn has spent much of her career pushing the boundaries of cancer treatment. As the Chair of Radiation Oncology at The Christie Hospital in Manchester, UK, she has dedicated herself to improving the outcomes of lung cancer patients. Her work bridges the gap between scientific research and real-world clinical practice, helping to develop treatments that are not just effective but also safer for patients.

Her academic journey led her to become a leader in combining radiotherapy with new drug therapies. This work has resulted in breakthroughs in treating small cell lung cancer and has had a lasting impact on treatment guidelines globally.

Breaking New Ground in Lung Cancer Treatment

One of Professor Faivre-Finn’s most significant contributions is her leadership in clinical trials that combine radiotherapy with molecular-based treatments. Her work with the RAPID-RT trial, for example, has shown how these combined therapies can improve treatment effectiveness while minimizing side effects for patients. She’s also co-leading the CONCORDE Phase I platform, exploring innovative new therapies for lung cancer.

Her innovative spirit doesn’t just stop at improving treatments—it’s also about empowering patients. By integrating patient feedback into her research, Professor Faivre-Finn ensures that the therapies she helps develop truly meet the needs of those undergoing treatment.

Championing Women in Oncology

Beyond her scientific achievements, Professor Faivre-Finn is an advocate for gender equality in oncology. She has worked tirelessly to support women in the field, mentoring early-career scientists and making sure their voices are heard in leadership roles. She’s been open about the challenges of balancing a high-powered career with family life, and her story is a beacon of hope for many aspiring oncologists.

OncoDaily x ESTRO 2025: A Partnership for the Future

OncoDaily is proud to announce its collaboration as an official media partner for ESTRO 2025. This partnership will allow us to bring you live updates, exclusive interviews, and in-depth coverage of one of the most important events in radiation oncology.

Held from May 2–6, 2025, in Vienna, Austria, the theme of this year’s congress—“Transformative Innovation Through Partnership”—reflects the essence of what makes ESTRO such a unique gathering.

What You Can Expect at ESTRO 2025

• A mission to ensure radiation therapy is accessible to all, aligning with ESTRO’s 2030 vision: “Radiation Oncology. Optimal Health for All, Together.”

• Breakthrough research, clinical trial updates, and a focus on collaboration across disciplines.

• A special Young Track dedicated to supporting and inspiring the next generation of oncology professionals.

• Europe’s largest exhibition focused on the latest in radiation oncology.

With OncoDaily’s coverage, you’ll get a front-row seat to all the highlights, from inspiring talks to groundbreaking findings. We’re excited to bring the global oncology community together, sharing real-time insights from the heart of the congress.

A Legacy of Impact

The Breur Award at ESTRO 2025 is not just a celebration of Professor Faivre-Finn’s past achievements; it’s a recognition of her ongoing impact on the future of lung cancer treatment. Her work continues to inspire change, improving the lives of patients and shaping the next generation of oncology professionals.

As Professor Faivre-Finn herself puts it:

“The true power of science lies in its ability to go beyond the lab and make a real difference in people’s lives.”

Her journey is a testament to what’s possible when innovation meets compassion.

Stay Inspired, Stay Informed

Professor Corinne Faivre-Finn’s story is a reminder that the future of cancer care is in the hands of those who push the limits of what’s possible.

Stay tuned to OncoDaily for more stories of change, inspiration, and live updates from ESTRO 2025.

Together, we are shaping the future of cancer treatment.